人工智能驱动的细分和2型糖尿病上心上脂肪组织的形态几何分析
Fan Feng1, Abdallah I Hasaballa2, Ting Long1
1Auckland Bioengineering Institute, The University of Auckland, 70 Symonds Street, Auckland, 1010, New Zealand.
Cardiovascular diabetology
|July 18, 2025
概括
这项研究引入了一种人工智能工具,用于分析2型糖尿病 (T2D) 的心上脂肪组织 (EAT). 人工智能准确地对EAT进行细分,并确定与心脏代谢风险相关的关键结构差异.
科学领域:
- 心血管成像 - 心血管成像
- 人工智能在医学中的应用
- 代谢性疾病研究研究
背景情况:
- 心脂肪组织 (EAT) 与2型糖尿病 (T2D) 的心脏代谢风险有关.
- 在T2D中EAT的空间分布和结构特征尚不清楚.
- 需要自动化方法来进行详细的EAT分析.
研究的目的:
- 开发一种新的,形状感知,基于人工智能的方法,用于EAT的自动细分.
- 在T2D患者中进行EAT的形态几何学分析.
- 为了确定与T2D中心脏代谢风险相关的EAT结构差异.
主要方法:
- 一个使用签名距离地图 (SDM) 的深度学习模型 (EAT-Seg) 已被开发用于EAT细分.
- 分析了来自90名参与者的心脏3D迪克森MRI数据 (45名T2D,45名对照).
- 使用统计形状分析和形态几何特征提取来比较群体之间的EAT.
主要成果:
- EAT-Seg显示出高分段精度 (DSC:0.881,HD95:3.213毫米,ASSD:0.602毫米). 通过使用 EAT-Seg,可以实现高分段精度.
- 在T2D和对照组之间观察到EAT的显著空间分布差异.
- 卷积和厚度梯度特征被确定为关键区分因素 (r > 0.8,P < 0.05),随机森林的AUC达到0.703.
结论:
- 人工智能框架提供了准确的EAT细分,即使对于复杂的结构.
- 在EAT的关键形态几何学差异与T2D相关.
- 这种方法显示了EAT作为心脏代谢风险评估中的生物标志物的潜力.
更多相关视频
10:28Isolation, Expansion, and Adipogenic Induction of CD34+CD31+ Endothelial Cells from Human Omental and Subcutaneous Adipose Tissue
Published on: July 17, 2018
11.9K
06:35Author Spotlight: Insights into Cardiometabolic Diseases with Subcutaneous Adipose Tissue Microvasculature Studies
Published on: April 5, 2024
1.1K
相关概念视频
01:24Obesity
The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in adipocytes...
01:26Type II Diabetes I: Introduction
Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance, in which target tissues such as the liver, muscle, and adipose tissue respond poorly to insulin. It is also associated with inadequate compensatory insulin secretion, where pancreatic β-cells fail to produce sufficient insulin. Together, these abnormalities lead to persistent hyperglycemia.EtiologyT2DM develops through a complex interaction of genetic predisposition and environmental or...
01:24Type II Diabetes II: Pathophysiology
PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.